Business Wire

CA-GLOBALITY

20.12.2022 14:01:34 CET | Business Wire | Press release

Share
Globality Wins “Best Use of Natural Language Processing” at 2022 Global Excellence Awards

Globality, the leader in using artificial intelligence and natural language processing (NLP) to transform the procurement function, today announced it has been named by The AI Journal as the winner of the Best Use of NLP in the 2022 Global Excellence Awards.

This was the biggest year yet for the awards program with more than 250 entries being submitted from across the world. Each entry was reviewed by a 28-person judging panel from across the world with the winner being selected by achieving the highest score. This year the judging panel included representatives from industry dominating brands such as HSBC, Google, Deloitte, Microsoft, and Amazon.

Powered by cutting-edge AI technology, Globality reinvents the procurement process by automating the demand creation, supplier identification, proposal evaluation, and statement of work (SOW) creation process – completely replacing the traditional, outdated Request for Proposal. Its self-service, consumer-like interface uses NLP and machine learning to understand buyers' needs and match companies with suppliers that best meet specific project requirements, all while achieving substantial cost savings and reducing operating expenses.

“We are proud to be recognized by The AI Journal and receive the prestigious Global Excellence Award for Best Use of NLP,” said Lior Delgo, Globality Co-Founder and President. “It reflects the growth and success of Globality’s game-changing AI-powered technology that is helping industry-leading companies such as BT and Santander transform their buying models to manage their company’s spend more efficiently than ever before.

“In today's economic climate especially, sourcing more intelligently and effectively is not just critical to protecting the bottom line, it is key to driving better business outcomes which is exactly what Globality’s technology is empowering our customers to do.”

“Globality has set a high standard for innovation and creativity with its winning entry in the category Best Use of NLP. With this being the biggest year yet, it made the competition for being a finalist tough with innovative, smart, thought-provoking, results-driven entries coming in from companies of all sizes. It is fantastic to see the effort and passion be rewarded by getting the global recognition by winning at the 2022 Global Excellence Awards,” said Tom Allen, Founder and CEO of The AI Journal.

About Globality – Option 1

Globality is the leader in using leading-edge, artificial intelligence-powered technology to dramatically increase cost savings and improve business outcomes that procurement facilitates. Globality’s state-of-the-art digital solution replaces the traditional, outdated Request for Proposal, efficiently and effectively scoping needs, and matches companies with the suppliers that best meet the specific project requirements. By using Globality’s platform, companies achieve substantial cost savings and reduced operating expenses, while also delighting business stakeholders, fostering collaboration, and improving outcomes. For more information, visit www.globality.com

About The AI Journal Global Excellence Awards

The AI Journal’s Global Excellence Awards is a program that recognizes best practices, use cases, campaigns, and exceptional talent from high-performing teams and individuals from companies of all sizes around the world.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221220005034/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye